The aim of this research is to improve the way in which we predict the outcome of this disease and develop clinical tests (biomarkers) which improve the management of alcoholic hepatitis and which help the pharmaceutical industry to run trials in this area.
Development of a prognostic scoring system
Development of a diagnostic test
Define a panel of markers for immune profiling
Establish in-vitro models to test novel therapeutic agents